Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data.

IF 9.4 1区 医学 Q1 UROLOGY & NEPHROLOGY
Chenxi Gao,Yunwen Xu,Sneha Mehta,Yingying Sang,Carina Flaherty,Aditya Surapaneni,Krutika Pandit,Alexander R Chang,Jamie Alton Green,Morgan E Grams,Jung-Im Shin
{"title":"Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data.","authors":"Chenxi Gao,Yunwen Xu,Sneha Mehta,Yingying Sang,Carina Flaherty,Aditya Surapaneni,Krutika Pandit,Alexander R Chang,Jamie Alton Green,Morgan E Grams,Jung-Im Shin","doi":"10.1053/j.ajkd.2025.03.021","DOIUrl":null,"url":null,"abstract":"RATIONALE & OBJECTIVES\r\nAccurate ascertainment of end-stage kidney disease (ESKD) in electronic health records (EHRs) data is important for much epidemiological research. This study aimed to develop and validate an algorithm using diagnosis and procedure codes to identify patients with ESKD (treated with maintenance dialysis or kidney transplantation) in EHRs data.\r\n\r\nSTUDY DESIGN\r\nStudy of diagnostic algorithms.\r\n\r\nSETTING & PARTICIPANTS\r\nThe development cohort included 559,615 patients treated at the Geisinger Health System (January 1996-June 2018). The validation cohort included 767,186 patients treated at New York University Langone Health System (January 2018-December 2020).\r\n\r\nALGORITHMS COMPARED\r\nAn algorithm developed using diagnosis and procedure codes compared to a nominal gold standard designation within the United States Renal Data System (USRDS) data. The performance of the algorithm was characterized by sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). The dates of incident ESKD between the algorithm and USRDS were compared in a subset of cases.\r\n\r\nOUTCOMES\r\nESKD (maintenance dialysis, prior recipient of a kidney transplant, or kidney transplantation surgery) cases.\r\n\r\nRESULTS\r\nIn Geisinger, we developed the ESKD algorithm that identified 4,766 (0.85%) ESKD cases, while there were 5,155 (0.92%) ESKD cases reported by the USRDS. The sensitivity, specificity, PPV, and NPV of the algorithm were 73.9% (95% CI, 72.7-75.1%), 99.83% (99.82-99.84%), 79.9% (78.9-81.0%), and 99.76% (99.75-99.77%), respectively. When applying the algorithm to New York University Langone Health System data, the sensitivity, specificity, PPV, and NPV were 71.8% (95% CI, 70.7-73.0%), 99.95% (99.95-99.96%), 91.6% (90.8-92.4%), and 99.79 (99.78-99.80%), respectively. The median (interquartile range) difference between dates of incident ESKD (algorithms minus USRDS) were -3 (-21 to 83) days in Geisinger and 0 (-12 to 69) days in New York University Langone Health.\r\n\r\nLIMITATIONS\r\nUse of structured EHRs data only.\r\n\r\nCONCLUSIONS\r\nAlgorithms combining diagnosis and procedure codes show high specificity and modest sensitivity for identifying patients with ESKD, providing a research tool to inform future EHR-based studies.","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"58 1","pages":""},"PeriodicalIF":9.4000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1053/j.ajkd.2025.03.021","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

RATIONALE & OBJECTIVES Accurate ascertainment of end-stage kidney disease (ESKD) in electronic health records (EHRs) data is important for much epidemiological research. This study aimed to develop and validate an algorithm using diagnosis and procedure codes to identify patients with ESKD (treated with maintenance dialysis or kidney transplantation) in EHRs data. STUDY DESIGN Study of diagnostic algorithms. SETTING & PARTICIPANTS The development cohort included 559,615 patients treated at the Geisinger Health System (January 1996-June 2018). The validation cohort included 767,186 patients treated at New York University Langone Health System (January 2018-December 2020). ALGORITHMS COMPARED An algorithm developed using diagnosis and procedure codes compared to a nominal gold standard designation within the United States Renal Data System (USRDS) data. The performance of the algorithm was characterized by sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). The dates of incident ESKD between the algorithm and USRDS were compared in a subset of cases. OUTCOMES ESKD (maintenance dialysis, prior recipient of a kidney transplant, or kidney transplantation surgery) cases. RESULTS In Geisinger, we developed the ESKD algorithm that identified 4,766 (0.85%) ESKD cases, while there were 5,155 (0.92%) ESKD cases reported by the USRDS. The sensitivity, specificity, PPV, and NPV of the algorithm were 73.9% (95% CI, 72.7-75.1%), 99.83% (99.82-99.84%), 79.9% (78.9-81.0%), and 99.76% (99.75-99.77%), respectively. When applying the algorithm to New York University Langone Health System data, the sensitivity, specificity, PPV, and NPV were 71.8% (95% CI, 70.7-73.0%), 99.95% (99.95-99.96%), 91.6% (90.8-92.4%), and 99.79 (99.78-99.80%), respectively. The median (interquartile range) difference between dates of incident ESKD (algorithms minus USRDS) were -3 (-21 to 83) days in Geisinger and 0 (-12 to 69) days in New York University Langone Health. LIMITATIONS Use of structured EHRs data only. CONCLUSIONS Algorithms combining diagnosis and procedure codes show high specificity and modest sensitivity for identifying patients with ESKD, providing a research tool to inform future EHR-based studies.
在电子健康记录数据中识别终末期肾脏疾病的算法验证。
理由与目的在电子健康档案(EHRs)数据中准确确定终末期肾脏疾病(ESKD)对许多流行病学研究具有重要意义。本研究旨在开发和验证一种使用诊断和程序代码的算法,以识别电子病历数据中的ESKD患者(接受维持性透析或肾移植治疗)。研究设计:诊断算法研究。环境和参与者:发展队列包括559,615名在Geisinger卫生系统(1996年1月至2018年6月)接受治疗的患者。验证队列包括767,186名在纽约大学朗格尼卫生系统(2018年1月至2020年12月)接受治疗的患者。compare一种使用诊断和程序代码开发的算法,与美国肾脏数据系统(USRDS)数据中的名义金标准名称进行比较。该算法具有敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)的特点。在一组病例中,比较了算法和USRDS之间的ESKD事件日期。结果:kd(维持性透析,既往肾移植接受者,或肾移植手术)病例。结果Geisinger开发的ESKD算法识别了4766例(0.85%)ESKD病例,而USRDS报告的ESKD病例为5155例(0.92%)。该算法的敏感性为73.9% (95% CI为72.7 ~ 75.1%),特异性为99.83% (99.82 ~ 99.84%),PPV为79.9% (78.9 ~ 81.0%),NPV为99.76%(99.75 ~ 99.77%)。将该算法应用于纽约大学朗格尼健康系统数据时,灵敏度、特异性、PPV和NPV分别为71.8% (95% CI, 70.7 ~ 73.0%)、99.95%(99.95 ~ 99.96%)、91.6%(90.8 ~ 92.4%)和99.79(99.78 ~ 99.80%)。事件ESKD(算法减去USRDS)日期之间的中位数(四分位数范围)差异在Geisinger为-3(-21至83)天,在纽约大学Langone健康中心为0(-12至69)天。限制:仅适用于结构化电子病历数据。结论结合诊断和程序代码的算法在识别ESKD患者方面具有高特异性和中等敏感性,为未来基于ehr的研究提供了一种研究工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Kidney Diseases
American Journal of Kidney Diseases 医学-泌尿学与肾脏学
CiteScore
20.40
自引率
2.30%
发文量
732
审稿时长
3-8 weeks
期刊介绍: The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信